Gallbladder Neoplasms: all 255 studies
Page 2 of 3. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00101036Phase 2Results posted
- Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or GallbladderTerminatedNCT00085410Phase 2Results posted
- Triapine and Gemcitabine Hydrochloride in Gallbladder CancerCompletedNCT00075504Phase 2Results posted
- S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00033540Phase 2Results posted
- Validation of Serum Metabolite Differences in Patients With Gallstones and Gallbladder CancerCompletedNCT07744477
- Validation of Differential Serum Levels for Five Minerals in South American Gallstone Patients With and Without Gallbladder CancerCompletedNCT07642817
- Validation of the Association Between the Abundance of Three Bacterial Genera in Stool Samples and the Risk of Gallbladder Cancer in South American Patients With GallstonesCompletedNCT07635745
- Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant TumorsCompletedNCT07319767
- Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract CancerSuspendedNCT07146646Phase 2
- Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder CancerCompletedNCT07092397
- A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationActive, not recruitingNCT07023731Phase 1/2
- Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract CancerActive, not recruitingNCT06717464Phase 2
- Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 2
- Outcomes and Prognostic Factors in HepatopancreatoduodenectomyCompletedNCT06631352
- Predicting Incidental Gallbladder CancerActive, not recruitingNCT06531408
- UCAD for Diagnosing Benign or Malignant Gallbladder Diseases and Follow-upActive, not recruitingNCT06232538
- Global Evaluation of Cholecystectomy Knowledge and OutcomesCompletedNCT06223061
- Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder CancerCompletedNCT06189664
- EEG Parameters Between Remimazolam- and Propofol-based AnesthesiaCompletedNCT06178848Not applicable
- Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract CancerActive, not recruitingNCT06178445Phase 2
- Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)Active, not recruitingNCT06109779Phase 3
- Addition of Everolimus to Standard of Care in Carcinoma GallbladderStatus unknownNCT05833815Phase 2/3
- Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder CancerStatus unknownNCT05718115
- Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.Status unknownNCT05620498Phase 2
- Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary CancerStatus unknownNCT05596370
- Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)Active, not recruitingNCT05564403Phase 2
- Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case ReportCompletedNCT05559229
- A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)Active, not recruitingNCT05506943Phase 2/3
- A Randomised Study of Consolidation CTRT Versus Observation After First Line Chemotherapy in Advanced Gallbladder CancerStatus unknownNCT05493956Not applicable
- The PLATON NetworkTerminatedNCT05489250
- To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsCompletedNCT05253053Phase 1/2
- A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-upStatus unknownNCT05237193
- Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma"Active, not recruitingNCT05222854
- A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsTerminatedNCT05194072Phase 1
- Biomarker Discovery in Patients With Advanced Biliary Tract CancerCompletedNCT04871321
- A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical ResectionStatus unknownNCT04856761
- Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsCompletedNCT04742959Phase 1/2
- Observational Study on Patients With Hepatobiliary TumorsStatus unknownNCT04637048
- Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract CancerTerminatedNCT04561453
- Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder CancerActive, not recruitingNCT04559139Phase 2/3
- Behavioral Weight Loss Program for Cancer Survivors in MarylandCompletedNCT04534309Not applicable
- PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)CompletedNCT04484636Not applicable
- A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic EngineeringCompletedNCT04426669Phase 1/2
- Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter HydrationStatus unknownNCT04362449Phase 2
- Two-in-one Covered and Uncovered Metal StentStatus unknownNCT04337333Not applicable
- Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder CancerStatus unknownNCT04333927Phase 2
- Validation of a Score That Predicts Residual Disease in Incidental Gallbladder CancerWithdrawnNCT04321577
- Neoadjuvant Gemcitabine Plus Cisplatin with or Without Durvalumab in Resectable Biliary Tract CancerActive, not recruitingNCT04308174Phase 2
- Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without BevacizumabCompletedNCT04164069Phase 1
- Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary MalignanciesActive, not recruitingNCT04068194Phase 1/2
- Study With Andes-1537 in Patients With Specific Types of Advanced Solid TumorCompletedNCT03985072Phase 1
- Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaStatus unknownNCT03772132Phase 2
- Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaStatus unknownNCT03768375Phase 2
- Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder CarcinomaStatus unknownNCT03702491Phase 2
- Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTCCompletedNCT03673072Phase 3
- Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosStatus unknownNCT03668418
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
- A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma PatientsStatus unknownNCT03581435
- Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder CancerWithdrawnNCT03579758Phase 3
- Selective Rather Than Routine Histopathological Examination Following Appendectomy and CholecystectomyCompletedNCT03510923
- Three Dimension Laparoscopic Versus Open Surgery for Gallbladder CarcinomaStatus unknownNCT03491878Not applicable
- Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA PatientsCompletedNCT03473574Phase 2
- Pembrolizumab in Biliary Tract CancerCompletedNCT03260712Phase 2
- Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerActive, not recruitingNCT03257761Phase 1
- International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)Status unknownNCT03210298
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownNCT03139487Phase 2
- Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)CompletedNCT03133286
- Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder CancersActive, not recruitingNCT02867865Phase 2/3
- Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaStatus unknownNCT02836847Phase 2
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader CarcinomaCompletedNCT02778308Not applicable
- Chile Biliary Longitudinal StudyCompletedNCT02692911
- T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive SystemStatus unknownNCT02662348Phase 1
- A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary ObstructionStatus unknownNCT02659852Not applicable
- Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable StudyStatus unknownNCT02646514Not applicable
- Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsActive, not recruitingNCT02495896Phase 1
- Irreversible Electroporation(IRE) For Unresectable Gallbladder NeoplasmsCompletedNCT02430662Not applicable
- Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or GallbladderCompletedNCT02375880Phase 1
- ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT02351765Phase 1
- Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT02333188Phase 1
- Alcohol Consumption and Gallbladder CancerCompletedNCT02326948
- Anesthetic Agents and Acute Kidney Injury After Liver Resection SurgeryWithdrawnNCT02174575Phase 4
- Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract CancerActive, not recruitingNCT02170090Phase 3
- A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary CancerActive, not recruitingNCT02151084Phase 2
- Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT01926236Phase 3
- Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD StentWithdrawnNCT01875549Not applicable
- Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By SurgeryWithdrawnNCT01859182Phase 2
- Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree CancerTerminatedNCT01855724Phase 2
- ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract CancerCompletedNCT01825603Phase 1
- Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesCompletedNCT01643499Phase 1
- Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related SymptomsCompletedNCT01640522Not applicable
- Initial Study of Gallbladder Cancer in ChileCompletedNCT01520259
- Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary StrictureCompletedNCT01320241Phase 2
- A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct CancerStatus unknownNCT01317069Phase 2
- Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by SurgeryCompletedNCT01313377Phase 3
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract CancerCompletedNCT01242605Phase 1
- B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
- Tomotherapy in Locally Advanced Gallbladder and Pancreatic CancersCompletedNCT01118897Phase 1/2
- New Chemotherapy Regimen in the Treatment of Advanced Gallbladder CarcinomaCompletedNCT01053390Phase 3